# Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori

> **NCT01645761** · NA · COMPLETED · sponsor: **Chuncheon Sacred Heart Hospital** · enrollment: 112 (actual)

## Conditions studied

- Gastric Ulcer Associated With Helicobacter Pylori

## Interventions

- **DRUG:** Endonase

## Key facts

- **NCT ID:** NCT01645761
- **Lead sponsor:** Chuncheon Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01645761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01645761, "Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01645761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*